Loading…

Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy

Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic p...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 2003-05, Vol.111 (10), p.1463-1474
Main Authors: Yamamoto, Shimako, Yang, Guiping, Zablocki, Daniela, Liu, Jing, Hong, Chull, Kim, Song-Jung, Soler, Sandra, Odashima, Mari, Thaisz, Jill, Yehia, Ghassan, Molina, Carlos A, Yatani, Atsuko, Vatner, Dorothy E, Vatner, Stephen F, Sadoshima, Junichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43
cites cdi_FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43
container_end_page 1474
container_issue 10
container_start_page 1463
container_title The Journal of clinical investigation
container_volume 111
creator Yamamoto, Shimako
Yang, Guiping
Zablocki, Daniela
Liu, Jing
Hong, Chull
Kim, Song-Jung
Soler, Sandra
Odashima, Mari
Thaisz, Jill
Yehia, Ghassan
Molina, Carlos A
Yatani, Atsuko
Vatner, Dorothy E
Vatner, Stephen F
Sadoshima, Junichi
description Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic protein kinase activated by proapoptotic stimuli in cardiac myocytes and that Mst1 causes cardiac myocyte apoptosis in vitro in a kinase activity-dependent manner. In vivo, cardiac-specific overexpression of Mst1 in transgenic mice results in activation of caspases, increased apoptosis, and dilated cardiomyopathy. Surprisingly, however, Mst1 prevents compensatory cardiac myocyte elongation or hypertrophy despite increased wall stress, thereby obscuring the use of the Frank-Starling mechanism, a fundamental mechanism by which the heart maintains cardiac output in response to increased mechanical load at the single myocyte level. Furthermore, Mst1 is activated by ischemia/reperfusion in the mouse heart in vivo. Suppression of endogenous Mst1 by cardiac-specific overexpression of dominant-negative Mst1 in transgenic mice prevents myocyte death by pathologic insults. These results show that Mst1 works as both an essential initiator of apoptosis and an inhibitor of hypertrophy in cardiac myocytes, resulting in a previously unrecognized form of cardiomyopathy.
doi_str_mv 10.1172/jci17459
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_200525347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>354385661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43</originalsourceid><addsrcrecordid>eNpFkE1LxDAQhoMouq6Cv0CCJy_VfLVpj8viJ4oXPZfsJLFZbFOTdKUXf7vVXfA0vMzDO8yD0BklV5RKdr0GR6XIqz00o3leZiXj5T6aEcJoVkleHqHjGNeEUCFycYiOKJM54VUxQ98LSG6jkvMd9hY_x0QxqCGaiLX7UMnoKQbtfDv6XqVmxKsRx-TaYVq67h2r3vfJRxfxl0uNHxIG3_amiyr5MOKN6VJwMNEBTxUwJoObsTchBd834wk6sOojmtPdnKO325vX5X329HL3sFw8ZSA4qTJLKBDKGC2KikKhSWFYwUHL0k5vCLBcS2Ast7Kw2gItbQFcClBQQamt4HN0se3tg_8cTEz12g-hm07WjJCc5VzICbrcQhB8jMHYug-uVWGsKal_PdePy4c_zxN6vusbVq3R_-BOLP8BtiZ7yw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200525347</pqid></control><display><type>article</type><title>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</title><source>NCBI_PubMed Central(免费)</source><source>EZB Electronic Journals Library</source><creator>Yamamoto, Shimako ; Yang, Guiping ; Zablocki, Daniela ; Liu, Jing ; Hong, Chull ; Kim, Song-Jung ; Soler, Sandra ; Odashima, Mari ; Thaisz, Jill ; Yehia, Ghassan ; Molina, Carlos A ; Yatani, Atsuko ; Vatner, Dorothy E ; Vatner, Stephen F ; Sadoshima, Junichi</creator><creatorcontrib>Yamamoto, Shimako ; Yang, Guiping ; Zablocki, Daniela ; Liu, Jing ; Hong, Chull ; Kim, Song-Jung ; Soler, Sandra ; Odashima, Mari ; Thaisz, Jill ; Yehia, Ghassan ; Molina, Carlos A ; Yatani, Atsuko ; Vatner, Dorothy E ; Vatner, Stephen F ; Sadoshima, Junichi</creatorcontrib><description>Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic protein kinase activated by proapoptotic stimuli in cardiac myocytes and that Mst1 causes cardiac myocyte apoptosis in vitro in a kinase activity-dependent manner. In vivo, cardiac-specific overexpression of Mst1 in transgenic mice results in activation of caspases, increased apoptosis, and dilated cardiomyopathy. Surprisingly, however, Mst1 prevents compensatory cardiac myocyte elongation or hypertrophy despite increased wall stress, thereby obscuring the use of the Frank-Starling mechanism, a fundamental mechanism by which the heart maintains cardiac output in response to increased mechanical load at the single myocyte level. Furthermore, Mst1 is activated by ischemia/reperfusion in the mouse heart in vivo. Suppression of endogenous Mst1 by cardiac-specific overexpression of dominant-negative Mst1 in transgenic mice prevents myocyte death by pathologic insults. These results show that Mst1 works as both an essential initiator of apoptosis and an inhibitor of hypertrophy in cardiac myocytes, resulting in a previously unrecognized form of cardiomyopathy.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/jci17459</identifier><identifier>PMID: 12750396</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Adenoviruses ; Alkaloids ; Animals ; Apoptosis ; Apoptosis - drug effects ; Benzophenanthridines ; Biomedical research ; Cardiomegaly - etiology ; Cardiomegaly - pathology ; Cardiomyopathy ; Cardiomyopathy, Dilated - etiology ; Cardiomyopathy, Dilated - pathology ; Cardiomyopathy, Dilated - physiopathology ; Cardiovascular disease ; Caspase 3 ; Caspases - metabolism ; Cell death ; Cells, Cultured ; Cytochrome ; Enzyme Activation - drug effects ; Enzyme Inhibitors - pharmacology ; Genes, Dominant ; Heart attacks ; Heart failure ; Heart Ventricles - pathology ; Ischemia ; Kinases ; Laboratories ; Mice ; Mice, Transgenic ; Myocardial Ischemia - genetics ; Myocardial Ischemia - metabolism ; Myocardial Ischemia - pathology ; Myocardial Reperfusion Injury - genetics ; Myocardial Reperfusion Injury - metabolism ; Myocardial Reperfusion Injury - pathology ; Myocardium - metabolism ; Myocardium - pathology ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Myocytes, Cardiac - pathology ; Organ Specificity ; Oxazoles - pharmacology ; Phenanthridines - pharmacology ; Protein-Serine-Threonine Kinases - genetics ; Protein-Serine-Threonine Kinases - metabolism ; Proteins ; Rats ; Rats, Wistar ; Transduction, Genetic ; Transgenic animals</subject><ispartof>The Journal of clinical investigation, 2003-05, Vol.111 (10), p.1463-1474</ispartof><rights>Copyright American Society for Clinical Investigation May 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43</citedby><cites>FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12750396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Shimako</creatorcontrib><creatorcontrib>Yang, Guiping</creatorcontrib><creatorcontrib>Zablocki, Daniela</creatorcontrib><creatorcontrib>Liu, Jing</creatorcontrib><creatorcontrib>Hong, Chull</creatorcontrib><creatorcontrib>Kim, Song-Jung</creatorcontrib><creatorcontrib>Soler, Sandra</creatorcontrib><creatorcontrib>Odashima, Mari</creatorcontrib><creatorcontrib>Thaisz, Jill</creatorcontrib><creatorcontrib>Yehia, Ghassan</creatorcontrib><creatorcontrib>Molina, Carlos A</creatorcontrib><creatorcontrib>Yatani, Atsuko</creatorcontrib><creatorcontrib>Vatner, Dorothy E</creatorcontrib><creatorcontrib>Vatner, Stephen F</creatorcontrib><creatorcontrib>Sadoshima, Junichi</creatorcontrib><title>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic protein kinase activated by proapoptotic stimuli in cardiac myocytes and that Mst1 causes cardiac myocyte apoptosis in vitro in a kinase activity-dependent manner. In vivo, cardiac-specific overexpression of Mst1 in transgenic mice results in activation of caspases, increased apoptosis, and dilated cardiomyopathy. Surprisingly, however, Mst1 prevents compensatory cardiac myocyte elongation or hypertrophy despite increased wall stress, thereby obscuring the use of the Frank-Starling mechanism, a fundamental mechanism by which the heart maintains cardiac output in response to increased mechanical load at the single myocyte level. Furthermore, Mst1 is activated by ischemia/reperfusion in the mouse heart in vivo. Suppression of endogenous Mst1 by cardiac-specific overexpression of dominant-negative Mst1 in transgenic mice prevents myocyte death by pathologic insults. These results show that Mst1 works as both an essential initiator of apoptosis and an inhibitor of hypertrophy in cardiac myocytes, resulting in a previously unrecognized form of cardiomyopathy.</description><subject>Adenoviruses</subject><subject>Alkaloids</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Benzophenanthridines</subject><subject>Biomedical research</subject><subject>Cardiomegaly - etiology</subject><subject>Cardiomegaly - pathology</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Dilated - etiology</subject><subject>Cardiomyopathy, Dilated - pathology</subject><subject>Cardiomyopathy, Dilated - physiopathology</subject><subject>Cardiovascular disease</subject><subject>Caspase 3</subject><subject>Caspases - metabolism</subject><subject>Cell death</subject><subject>Cells, Cultured</subject><subject>Cytochrome</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Genes, Dominant</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Heart Ventricles - pathology</subject><subject>Ischemia</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Myocardial Ischemia - genetics</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Ischemia - pathology</subject><subject>Myocardial Reperfusion Injury - genetics</subject><subject>Myocardial Reperfusion Injury - metabolism</subject><subject>Myocardial Reperfusion Injury - pathology</subject><subject>Myocardium - metabolism</subject><subject>Myocardium - pathology</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myocytes, Cardiac - pathology</subject><subject>Organ Specificity</subject><subject>Oxazoles - pharmacology</subject><subject>Phenanthridines - pharmacology</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Transduction, Genetic</subject><subject>Transgenic animals</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LxDAQhoMouq6Cv0CCJy_VfLVpj8viJ4oXPZfsJLFZbFOTdKUXf7vVXfA0vMzDO8yD0BklV5RKdr0GR6XIqz00o3leZiXj5T6aEcJoVkleHqHjGNeEUCFycYiOKJM54VUxQ98LSG6jkvMd9hY_x0QxqCGaiLX7UMnoKQbtfDv6XqVmxKsRx-TaYVq67h2r3vfJRxfxl0uNHxIG3_amiyr5MOKN6VJwMNEBTxUwJoObsTchBd834wk6sOojmtPdnKO325vX5X329HL3sFw8ZSA4qTJLKBDKGC2KikKhSWFYwUHL0k5vCLBcS2Ast7Kw2gItbQFcClBQQamt4HN0se3tg_8cTEz12g-hm07WjJCc5VzICbrcQhB8jMHYug-uVWGsKal_PdePy4c_zxN6vusbVq3R_-BOLP8BtiZ7yw</recordid><startdate>200305</startdate><enddate>200305</enddate><creator>Yamamoto, Shimako</creator><creator>Yang, Guiping</creator><creator>Zablocki, Daniela</creator><creator>Liu, Jing</creator><creator>Hong, Chull</creator><creator>Kim, Song-Jung</creator><creator>Soler, Sandra</creator><creator>Odashima, Mari</creator><creator>Thaisz, Jill</creator><creator>Yehia, Ghassan</creator><creator>Molina, Carlos A</creator><creator>Yatani, Atsuko</creator><creator>Vatner, Dorothy E</creator><creator>Vatner, Stephen F</creator><creator>Sadoshima, Junichi</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>S0X</scope></search><sort><creationdate>200305</creationdate><title>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</title><author>Yamamoto, Shimako ; Yang, Guiping ; Zablocki, Daniela ; Liu, Jing ; Hong, Chull ; Kim, Song-Jung ; Soler, Sandra ; Odashima, Mari ; Thaisz, Jill ; Yehia, Ghassan ; Molina, Carlos A ; Yatani, Atsuko ; Vatner, Dorothy E ; Vatner, Stephen F ; Sadoshima, Junichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adenoviruses</topic><topic>Alkaloids</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Benzophenanthridines</topic><topic>Biomedical research</topic><topic>Cardiomegaly - etiology</topic><topic>Cardiomegaly - pathology</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Dilated - etiology</topic><topic>Cardiomyopathy, Dilated - pathology</topic><topic>Cardiomyopathy, Dilated - physiopathology</topic><topic>Cardiovascular disease</topic><topic>Caspase 3</topic><topic>Caspases - metabolism</topic><topic>Cell death</topic><topic>Cells, Cultured</topic><topic>Cytochrome</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Genes, Dominant</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Heart Ventricles - pathology</topic><topic>Ischemia</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Myocardial Ischemia - genetics</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Ischemia - pathology</topic><topic>Myocardial Reperfusion Injury - genetics</topic><topic>Myocardial Reperfusion Injury - metabolism</topic><topic>Myocardial Reperfusion Injury - pathology</topic><topic>Myocardium - metabolism</topic><topic>Myocardium - pathology</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myocytes, Cardiac - pathology</topic><topic>Organ Specificity</topic><topic>Oxazoles - pharmacology</topic><topic>Phenanthridines - pharmacology</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Transduction, Genetic</topic><topic>Transgenic animals</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Shimako</creatorcontrib><creatorcontrib>Yang, Guiping</creatorcontrib><creatorcontrib>Zablocki, Daniela</creatorcontrib><creatorcontrib>Liu, Jing</creatorcontrib><creatorcontrib>Hong, Chull</creatorcontrib><creatorcontrib>Kim, Song-Jung</creatorcontrib><creatorcontrib>Soler, Sandra</creatorcontrib><creatorcontrib>Odashima, Mari</creatorcontrib><creatorcontrib>Thaisz, Jill</creatorcontrib><creatorcontrib>Yehia, Ghassan</creatorcontrib><creatorcontrib>Molina, Carlos A</creatorcontrib><creatorcontrib>Yatani, Atsuko</creatorcontrib><creatorcontrib>Vatner, Dorothy E</creatorcontrib><creatorcontrib>Vatner, Stephen F</creatorcontrib><creatorcontrib>Sadoshima, Junichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>SIRS Editorial</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Shimako</au><au>Yang, Guiping</au><au>Zablocki, Daniela</au><au>Liu, Jing</au><au>Hong, Chull</au><au>Kim, Song-Jung</au><au>Soler, Sandra</au><au>Odashima, Mari</au><au>Thaisz, Jill</au><au>Yehia, Ghassan</au><au>Molina, Carlos A</au><au>Yatani, Atsuko</au><au>Vatner, Dorothy E</au><au>Vatner, Stephen F</au><au>Sadoshima, Junichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2003-05</date><risdate>2003</risdate><volume>111</volume><issue>10</issue><spage>1463</spage><epage>1474</epage><pages>1463-1474</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic protein kinase activated by proapoptotic stimuli in cardiac myocytes and that Mst1 causes cardiac myocyte apoptosis in vitro in a kinase activity-dependent manner. In vivo, cardiac-specific overexpression of Mst1 in transgenic mice results in activation of caspases, increased apoptosis, and dilated cardiomyopathy. Surprisingly, however, Mst1 prevents compensatory cardiac myocyte elongation or hypertrophy despite increased wall stress, thereby obscuring the use of the Frank-Starling mechanism, a fundamental mechanism by which the heart maintains cardiac output in response to increased mechanical load at the single myocyte level. Furthermore, Mst1 is activated by ischemia/reperfusion in the mouse heart in vivo. Suppression of endogenous Mst1 by cardiac-specific overexpression of dominant-negative Mst1 in transgenic mice prevents myocyte death by pathologic insults. These results show that Mst1 works as both an essential initiator of apoptosis and an inhibitor of hypertrophy in cardiac myocytes, resulting in a previously unrecognized form of cardiomyopathy.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>12750396</pmid><doi>10.1172/jci17459</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 2003-05, Vol.111 (10), p.1463-1474
issn 0021-9738
1558-8238
language eng
recordid cdi_proquest_journals_200525347
source NCBI_PubMed Central(免费); EZB Electronic Journals Library
subjects Adenoviruses
Alkaloids
Animals
Apoptosis
Apoptosis - drug effects
Benzophenanthridines
Biomedical research
Cardiomegaly - etiology
Cardiomegaly - pathology
Cardiomyopathy
Cardiomyopathy, Dilated - etiology
Cardiomyopathy, Dilated - pathology
Cardiomyopathy, Dilated - physiopathology
Cardiovascular disease
Caspase 3
Caspases - metabolism
Cell death
Cells, Cultured
Cytochrome
Enzyme Activation - drug effects
Enzyme Inhibitors - pharmacology
Genes, Dominant
Heart attacks
Heart failure
Heart Ventricles - pathology
Ischemia
Kinases
Laboratories
Mice
Mice, Transgenic
Myocardial Ischemia - genetics
Myocardial Ischemia - metabolism
Myocardial Ischemia - pathology
Myocardial Reperfusion Injury - genetics
Myocardial Reperfusion Injury - metabolism
Myocardial Reperfusion Injury - pathology
Myocardium - metabolism
Myocardium - pathology
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
Myocytes, Cardiac - pathology
Organ Specificity
Oxazoles - pharmacology
Phenanthridines - pharmacology
Protein-Serine-Threonine Kinases - genetics
Protein-Serine-Threonine Kinases - metabolism
Proteins
Rats
Rats, Wistar
Transduction, Genetic
Transgenic animals
title Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A12%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20Mst1%20causes%20dilated%20cardiomyopathy%20by%20stimulating%20apoptosis%20without%20compensatory%20ventricular%20myocyte%20hypertrophy&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Yamamoto,%20Shimako&rft.date=2003-05&rft.volume=111&rft.issue=10&rft.spage=1463&rft.epage=1474&rft.pages=1463-1474&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/jci17459&rft_dat=%3Cproquest_cross%3E354385661%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=200525347&rft_id=info:pmid/12750396&rfr_iscdi=true